4//SEC Filing
Wise John Drayton 4
Accession 0001628280-25-004460
CIK 0001104506other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:11 PM ET
Size
8.2 KB
Accession
0001628280-25-004460
Insider Transaction Report
Form 4
INSMED IncINSM
Wise John Drayton
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-02-05+15,373→ 140,935 total - Sale
Common Stock
2025-02-07$78.91/sh−10$789→ 133,015 total - Sale
Common Stock
2025-02-06$80.90/sh−7,910$639,919→ 133,025 total
Footnotes (3)
- [F1]Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.
- [F2]Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.
- [F3]This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Documents
Issuer
INSMED Inc
CIK 0001104506
Entity typeother
Related Parties
1- filerCIK 0001930805
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 5:11 PM ET
- Size
- 8.2 KB